Clik here to view.
New Company, Velsera, Represents Summa Equity’s Vision to Improve Global...
BOSTON & SAN FRANCISCO & STOCKHOLM New company Velsera was announced today at the J.P. Morgan Healthcare Conference in San Francisco, California. The vision for Velsera is supported by...
View ArticleClik here to view.
ALiA BioTech’s One-stop Diagnostic Platform Brings Multiplex Testing to the...
HONG KONG Driven by the Covid-19 pandemic, the market for point-of-care testing (POCT) is seen to double in size compared to pre-pandemic levels. In this burgeoning field, multiplexing is the key...
View ArticleClik here to view.
Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the...
BOCA RATON, Fla. Akron Bio (“Akron”), a leading supplier of critical inputs for cell and gene therapies, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has granted...
View ArticleClik here to view.
BeiGene Presents New Research from Tislelizumab Global Development Program at...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, will share clinical data and patient-reported outcomes for...
View ArticleClik here to view.
Longevity Biotech Gero Entered a Research Collaboration With Pfizer to...
SAN FRANCISCO Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for...
View ArticleClik here to view.
アクロン・バイオ、臨床細胞治療薬の製造におけるウイルス不活化ヒトフィブロネクチンの商業化について、日本のPMDAから適格性の確認を受ける
米フロリダ州ボカラトン （ビジネスワイヤ） —...
View ArticleClik here to view.
BeiGene Announces Expansion of Coverage on China’s National Reimbursement...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the National Reimbursement Drug List...
View ArticleClik here to view.
Kaneka Eurogentec社 mRNAのGMP製造能力を増強
東京 （ビジネスワイヤ） — 株式会社カネカ（本社：東京都港区、社長：田中 稔）はグループ会社Kaneka Eurogentec社（本社：ベルギー王国リエージュ州、社長：Lieven...
View ArticleClik here to view.
Kaneka expands GMP manufacturing capacity for mRNA in Kaneka Eurogentec S.A.
TOKYO Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has decided to increase its GMP*1 manufacturing capacity for mRNA*2 in Kaneka Eurogentec S.A....
View ArticleClik here to view.
Repare Therapeutics Receives $1.5 Million (¥200 million) Payment from Ono...
CAMBRIDGE, Mass. & MONTREAL Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that the Company has...
View ArticleClik here to view.
Kaneka扩张Kaneka Eurogentec S.A.旗下mRNA产品的GMP生产能力
东京 (美国商业资讯)–Kaneka Corporation（总部：东京都港区；总裁：Minoru Tanaka）(TOKYO:4118)决定在其全资拥有的欧洲地区集团公司Kaneka Eurogentec S.A.（总部：比利时列日；总裁：Lieven...
View ArticleClik here to view.
Genexine Receives Fast Track Designation from Korean Health Authority (MFDS)...
SEOUL, South Korea Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of...
View ArticleClik here to view.
KSQ Therapeutics Announces Ono Pharmaceutical Co., Ltd. is Acquiring Multiple...
LEXINGTON, Mass. KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using its proprietary, integrated discovery CRISPRomics...
View ArticleClik here to view.
2023 Japan Prize Laureates Announced
TOKYO The Japan Prize Foundation announced the winners of the 2023 Japan prize at 13:00 today, 30 January 2023 (JST). Prof. Masataka Nakazawa and Mr. Kazuo Hagimoto are co-winners of the Japan Prize...
View ArticleClik here to view.
2023年日本奖获奖者名单揭晓
东京 (美国商业资讯)–日本奖基金会(The Japan Prize Foundation)于日本标准时间2023年1月30日13:00公布了2023年日本奖的获奖者名单。Masataka Nakazawa教授和Kazuo Hagimoto先生共同获得电子、信息和通信领域的日本奖，Gero Miesenböck教授和Karl Deisseroth教授共同获得生命科学领域的日本奖。...
View ArticleClik here to view.
New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging...
MADISON, Wis. New chemistry for DNA analysis will empower forensic laboratories to overcome common challenges including degraded and contaminated samples. PowerPlex® 35GY System, launched today by...
View ArticleClik here to view.
Shin-Nihon Public Affairs Announces Yasuhisa Shiozaki to join as Special Advisor
TOKYO Shin-Nihon Public Affairs Co. (Head Office: Tokyo; President: Yasushi Kohara) today announced Mr. Yasuhisa Shiozaki as special advisor. Mr. Shiozaki is a former Chief Cabinet Secretary, and...
View ArticleClik here to view.
武田薬品工業: パイプラインの進展と2つのターゲットを絞った取得案件により長期的成長に向け加速、2022年度第3四半期も力強い業績を達成
大阪 （ビジネスワイヤ） – 武田薬品工業株式会社（TOKYO:4502/NYSE:TAK）は、本日、2022年度第3四半期の業績を公表しましたのでお知らせします。 当社チーフ フィナンシャル オフィサーのコスタ・サルウコス（Costa Saroukos）は次のように述べています。...
View ArticleClik here to view.
Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two...
OSAKA, Japan Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the third quarter of fiscal year 2022 (period ended December 31, 2022). Takeda chief financial officer, Costa...
View ArticleClik here to view.
武田通过推进管线建设和两项针对性收购加强长期增长；2022财年第三季度再次实现强劲业绩
日本大阪 (美国商业资讯)–武田(TOKYO:4502/NYSE:TAK)今天公布了2022财年第三季度（截至2022年12月31日）的财务业绩。 武田首席财务官Costa Saroukos评论道：...
View Article